Digital therapeutics refers to health or social care interventions delivered through a smart device to support healthy behaviors and provide therapeutic effects. Digital therapies/programs are cost-effective and have the potential to improve patient engagement and bring a substantial change in patients’ health. Owing to these advantages, digital therapeutics is increasingly being prescribed to help manage long-term conditions such as diabetes, insomnia, and asthma.
Scope of the Report:
This report focuses on the Digital Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Digital Therapeutics Market growth is driven by the incidence of preventable chronic diseases, rising focus on preventive healthcare, technological advancements, growing need to control healthcare costs, significant increase in venture capital investments, ...
Table of Contents
1 Market Overview
1.1 Digital Therapeutics Introduction
1.2 Market Analysis by Type
1.3 Market Analysis by Applications
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
184.108.40.206 United States Market States and Outlook (2013-2023)
220.127.116.11 Canada Market States and Outlook (2013-2023)
18.104.22.168 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
22.214.171.124 Germany Market States and Outlook (2013-2023)
126.96.36.199 France Market States and Outlook (2013-2023)
188.8.131.52 UK Market States and Outlook (2013-2023)
184.108.40.206 Russia Market States and Outlook (2013-2023)
220.127.116.11 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)